151 related articles for article (PubMed ID: 7575116)
1. The association between melanoma, lymphoma, and other primary neoplasms.
Riou JP; Ariyan S; Brandow KR; Fielding LP
Arch Surg; 1995 Oct; 130(10):1056-61. PubMed ID: 7575116
[TBL] [Abstract][Full Text] [Related]
2. Second malignancies in melanoma patients in Thuringia.
Wolff J; Wollina U
J Eur Acad Dermatol Venereol; 2000 Nov; 14(6):479-83. PubMed ID: 11444270
[TBL] [Abstract][Full Text] [Related]
3. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
4. Basal cell skin cancer and the risk of second primary cancers: a cancer registry-based study in Lithuania.
Krilaviciute A; Vincerzevskiene I; Smailyte G
Ann Epidemiol; 2016 Jul; 26(7):511-514. PubMed ID: 27262816
[TBL] [Abstract][Full Text] [Related]
5. Second primary tumors in patients with cutaneous malignant melanoma.
Bhatia S; Estrada-Batres L; Maryon T; Bogue M; Chu D
Cancer; 1999 Nov; 86(10):2014-20. PubMed ID: 10570426
[TBL] [Abstract][Full Text] [Related]
6. Malignant melanoma: it pays to be a woman.
Mashiah J; Brenner S
Skinmed; 2003; 2(3):183-7. PubMed ID: 14673297
[No Abstract] [Full Text] [Related]
7. Metachronous primary melanoma and lymphoma.
McIntosh BC; Ariyan S; Esche G; Zelterman D; Narayan D
Ann Plast Surg; 2010 Feb; 64(2):229-32. PubMed ID: 20098111
[TBL] [Abstract][Full Text] [Related]
8. Malignant tumors of the nasal cavity: review of a 60-case series.
Haraguchi H; Ebihara S; Saikawa M; Mashima K; Haneda T; Hirano K
Jpn J Clin Oncol; 1995 Oct; 25(5):188-94. PubMed ID: 7474406
[TBL] [Abstract][Full Text] [Related]
9. The risk of developing non-melanoma skin cancer, lymphoma and melanoma in patients with psoriasis in Taiwan: a 10-year, population-based cohort study.
Lee MS; Lin RY; Chang YT; Lai MS
Int J Dermatol; 2012 Dec; 51(12):1454-60. PubMed ID: 23171012
[TBL] [Abstract][Full Text] [Related]
10. Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients.
Statius Muller MG; van Leeuwen PA; van Diest PJ; Pijpers R; Nijveldt RJ; Vuylsteke RJ; Meijer S
World J Surg; 2002 Dec; 26(12):1405-11. PubMed ID: 12297910
[TBL] [Abstract][Full Text] [Related]
11. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.
Ai WZ; Keegan TH; Press DJ; Yang J; Pincus LB; Kim YH; Chang ET
JAMA Dermatol; 2014 Jul; 150(7):709-15. PubMed ID: 24718769
[TBL] [Abstract][Full Text] [Related]
12. Second primary melanomas: incidence and outcome.
Bower MR; Scoggins CR; Martin RC; Mays MP; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Noyes RD; Sussman JJ; Hagendoorn LJ; Stromberg AJ; McMasters K
Am Surg; 2010 Jul; 76(7):675-81. PubMed ID: 20698369
[TBL] [Abstract][Full Text] [Related]
13. Incidence of second neoplasms in patients with MALT lymphoma: no increase in risk above the background population.
Au WY; Gascoyne RD; Le N; Viswanatha DS; Klasa RJ; Gallagher R; Connors JM
Ann Oncol; 1999 Mar; 10(3):317-21. PubMed ID: 10355576
[TBL] [Abstract][Full Text] [Related]
14. Association between multiple cutaneous melanoma and other primary neoplasms.
Manganoni AM; Pavoni L; Farisoglio C; Sereni E; Chiudinelli M; Calzavara-Pinton P
Clin Exp Dermatol; 2012 Dec; 37(8):857-61. PubMed ID: 23020153
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
[TBL] [Abstract][Full Text] [Related]
16. Lymphoma-associated skin cancer: incidence, natural history, and clinical management.
Brewer JD; Habermann TM; Shanafelt TD
Int J Dermatol; 2014 Mar; 53(3):267-74. PubMed ID: 24320558
[TBL] [Abstract][Full Text] [Related]
17. Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011.
Moore MM; Geller AC; Warton EM; Schwalbe J; Asgari MM
J Am Acad Dermatol; 2015 Oct; 73(4):630-6. PubMed ID: 26298295
[TBL] [Abstract][Full Text] [Related]
18. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.
Amber KT; Bloom R; Nouri K
Am J Clin Dermatol; 2016 Feb; 17(1):71-7. PubMed ID: 26386881
[TBL] [Abstract][Full Text] [Related]
19. Risk of second primary malignancies in patients with cutaneous melanoma.
Schmid-Wendtner MH; Baumert J; Wendtner CM; Plewig G; Volkenandt M
Br J Dermatol; 2001 Dec; 145(6):981-5. PubMed ID: 11899153
[TBL] [Abstract][Full Text] [Related]
20. Cancer in adolescents and young adults (15-29 years): a population-based study in the Netherlands 1989-2009.
Aben KK; van Gaal C; van Gils NA; van der Graaf WT; Zielhuis GA
Acta Oncol; 2012 Sep; 51(7):922-33. PubMed ID: 22934554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
